Asia‘s Premier Hybrid Partnering Event
2022.10.12 Wed. -14 Fri.PACIFICO Yokohama
Research and development phase
Modality
Target disease
Target
Technology
R&D Services
AI・Digital
Diagnostics / Analytics Tools
Equipment, Devices
Genome Editing / Processing Technology
Infrastructure (Facility / Transport)
Digital Therapeutics (DTx)
Digital Medicine
Healthcare
Materials
Environment / Energy
Production / Manufacturing process
Bio-data Utilization
Intellectual Property, Legal and Financial Services
Universities, Bio-clusters and Public Support
Other Services